Ro52/TRIM21-deficient Expression and Function in Different Subsets of Peripheral Blood Mononuclear Cells is Associated with a Proinflammatory Cytokine Response in Patients with Idiopathic Inflammatory Myopathies

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2016 Dec 10

PMID 27936488

Citations 4

Authors

D Gomez-Martin

A S Galindo-Feria

A Barrera-Vargas

J Merayo-Chalico

G Juarez-Vega

J Torres-Ruiz

J Alcocer-Varela

Affiliations

Soon will be listed here.

Abstract

The presence of anti-Ro52/tripartite motif 21 (Trim21) autoantibodies has been associated with a distinctive clinical profile and has gained value as a prognostic marker in idiopathic inflammatory myopathies (IIM). The aim of the present work was to analyse Ro52/Trim21 expression in different subsets of peripheral blood mononuclear cells (PBMCs) of patients with IIM, as well as the ubiquitination profile and its association with proinflammatory cytokine production. We included 18 patients with recent-onset IIM and 18 age- and gender-matched healthy donors. PBMCs were isolated and different subsets (CD4 , CD8 , CD14 ) were purified by magnetic selection. The expression of Ro52/Trim21 in different PBMC subsets of patients with IIM and healthy donors was analysed by Western blot. We assessed the presence of myositis-specific and associated autoantibodies by enzyme-linked immunosorbent assay (ELISA). Cytokine levels were measured by cytometric bead array. Patients with IIM showed decreased protein expression of Ro52/Trim21 in comparison to healthy controls in PBMC (0·97 ± 0·60 versus 1·84 ± 0·92, P = 0·016), CD4 lymphocytes (0·79 ± 0·54 versus 2·41 ± 0·78, P = 0·017), and monocytes (0·87 ± 0·35 versus 1·89 ± 0·20, P < 0·001). There were no significant differences among IIM groups. Also, a lower K48-mediated ubiquitination profile was found, predominantly in CD4 lymphocytes. Furthermore, after mitogenic stimulation, there was a higher synthesis of proinflammatory cytokines by T cells [interleukin (IL)-17A and tumour necrosis factor (TNF)-α] and monocytes [IL-6 and interferon (IFN)-α] from IIM patients compared with healthy controls. Our data suggest that patients with IIM, mainly DM, are characterized by a deficient expression of Ro52/TRIM21 in different PBMC subsets (CD4 lymphocytes and monocytes), along with lower K48-mediated ubiquitination, which is associated with a proinflammatory cytokine response.

Citing Articles

Development and validation of a TRIM27-based nomogram for predicting metachronous liver metastasis and prognosis in postoperative colorectal cancer patients.

Zhu J, Zhi S, Zeng J, Zhou S, Ji Y, Han F BMC Cancer. 2024; 24(1):1142.

PMID: 39266987 PMC: 11396292. DOI: 10.1186/s12885-024-12890-7.

Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.

Gong X, He S, Cai P Front Immunol. 2024; 15:1435525.

PMID: 39165359 PMC: 11333224. DOI: 10.3389/fimmu.2024.1435525.

Targeted proteomics in a population-based study identifies serum PECAM-1 and TRIM21 as inflammation markers for periodontitis.

Reckelkamm S, Kaminska I, Baumeister S, Ponce-de-Leon M, Ehmke B, Rodakowska E Clin Oral Investig. 2023; 28(1):59.

PMID: 38157091 PMC: 10756891. DOI: 10.1007/s00784-023-05442-z.

Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners.

Gallardo-Vara E, Ruiz-Llorente L, Casado-Vela J, Ruiz-Rodriguez M, Lopez-Andres N, Pattnaik A Cells. 2019; 8(9).

PMID: 31540324 PMC: 6769930. DOI: 10.3390/cells8091082.

References

Nisole S, Stoye J, Saib A . TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005; 3(10):799-808. DOI: 10.1038/nrmicro1248. View

Ghillani P, Andre C, Toly C, Rouquette A, Bengoufa D, Nicaise P . Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. Autoimmun Rev. 2011; 10(9):509-13. DOI: 10.1016/j.autrev.2011.03.004. View

Marie I . Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep. 2012; 14(3):275-85. DOI: 10.1007/s11926-012-0249-3. View

Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana F . Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med. 2009; 206(8):1661-71. PMC: 2722164. DOI: 10.1084/jem.20090585. View

Espinosa A, Hennig J, Ambrosi A, Anandapadmanaban M, Abelius M, Sheng Y . Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface. J Biol Chem. 2011; 286(42):36478-91. PMC: 3196112. DOI: 10.1074/jbc.M111.241786. View

Versteeg G, Benke S, Garcia-Sastre A, Rajsbaum R . InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins. Cytokine Growth Factor Rev. 2014; 25(5):563-76. PMC: 7173094. DOI: 10.1016/j.cytogfr.2014.08.001. View

Moran E, Mastaglia F . The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscul Disord. 2014; 24(11):943-52. DOI: 10.1016/j.nmd.2014.06.432. View

Fletcher A, Mallery D, Watkinson R, Dickson C, James L . Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc Natl Acad Sci U S A. 2015; 112(32):10014-9. PMC: 4538650. DOI: 10.1073/pnas.1507534112. View

Higgs R, Lazzari E, Wynne C, Gabhann J, Espinosa A, Wahren-Herlenius M . Self protection from anti-viral responses--Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors. PLoS One. 2010; 5(7):e11776. PMC: 2909902. DOI: 10.1371/journal.pone.0011776. View

10.

Versteeg G, Rajsbaum R, Sanchez-Aparicio M, Maestre A, Valdiviezo J, Shi M . The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity. 2013; 38(2):384-98. PMC: 3584420. DOI: 10.1016/j.immuni.2012.11.013. View

11.

Gomez-Martin D, Ibarra-Sanchez M, Romo-Tena J, Cruz-Ruiz J, Esparza-Lopez J, Galindo-Campos M . Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus. Arthritis Rheum. 2013; 65(4):1032-42. DOI: 10.1002/art.37833. View

12.

Bhoj V, Chen Z . Ubiquitylation in innate and adaptive immunity. Nature. 2009; 458(7237):430-7. DOI: 10.1038/nature07959. View

13.

Kong H, Anderson D, Lee C, Jang M, Tamura T, Tailor P . Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol. 2007; 179(1):26-30. DOI: 10.4049/jimmunol.179.1.26. View

14.

Oke V, Wahren-Herlenius M . The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J Autoimmun. 2012; 39(1-2):77-82. DOI: 10.1016/j.jaut.2012.01.014. View

15.

Yoshimi R, Chang T, Wang H, Atsumi T, Morse 3rd H, Ozato K . Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J Immunol. 2009; 182(12):7527-38. PMC: 2803686. DOI: 10.4049/jimmunol.0804121. View

16.

Marie I, Hatron P, Dominique S, Cherin P, Mouthon L, Menard J . Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum. 2011; 41(6):890-9. DOI: 10.1016/j.semarthrit.2011.09.008. View

17.

Young J, Sermwittayawong D, Kim H, Nandu S, An N, Erdjument-Bromage H . Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production. J Biol Chem. 2010; 286(8):6521-31. PMC: 3057824. DOI: 10.1074/jbc.M110.172288. View

18.

Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J . Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther. 2007; 26(6):831-8. DOI: 10.1111/j.1365-2036.2007.03433.x. View

19.

Menendez A, Gomez J, Caminal-Montero L, Diaz-Lopez J, Cabezas-Rodriguez I, Mozo L . Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus. ScientificWorldJournal. 2013; 2013:832789. PMC: 3833022. DOI: 10.1155/2013/832789. View

20.

Palombella V, Rando O, GOLDBERG A, Maniatis T . The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994; 78(5):773-85. DOI: 10.1016/s0092-8674(94)90482-0. View